Four main therapeutic keys for Parkinson’s disease: A mini review
نویسندگان
1 CONACYT-Instituto de Neuroetologia, Universidad Veracruzana, Xalapa, Veracruz, Mexico
2 IIIT Srikakulam, Rajiv Gandhi University of Knowledge Technologies (RGUKT); International collaboration ID:1840; India
3 Centro de Investigacion Biomedica del Noreste. IMSS. Monterrey, Nuevo Leon. Mexico
4 Instituto de Neuroetologia, Universidad Veracruzana. Xalapa, Veracruz, Mexico
5 Instituto de Neuroetologia, Universidad Veracruzana. Xalapa, Veracruz, Mexico
6 Facultad de Medicina. Universidad Autonoma de Nuevo Leon. Monterrey, Nuevo Leon, Mexico
doi
10.22038/ijbms.2019.33659.8025چکیده
Objective(s): Parkinson’s disease (PD) is characterized by motor and cognitive dysfunctions. The progressive degeneration of dopamine-producing neurons that are present in the substantia nigra pars compacta (SNpc) has been the main focus of study and PD therapies since ages.Materials and Methods: In this manuscript, a systematic revision of experimental and clinical evidence of PD-associated cell process was conducted. Results: Classically, the damage in the dopaminergic neuronal circuits of SNpc is favored by reactive oxidative/nitrosative stress, leading to cell death. Interestingly, the therapy for PD has only focused on avoiding the symptom progression but not in finding a complete reversion of the disease. Recent evidence suggests that the renin-angiotensin system imbalance and neuroinflammation are the main keys in the progression of experimental PD. Conclusion: The progression of neurodegeneration in SNpc is due to the complex interaction of multiple processes. In this review, we analyzed the main contribution of four cellular processes and discussed in the perspective of novel experimental approaches.
